Peptide pt 141 (the second name is bremelanotide) is an isomer of melanotane and was first developed by Palatin Technologies. The difference between melanotan-2 and bremelanotide is that pt-141 is a metabolite of melanotane with an amide C-terminal absent in it. At one time the drug was tested on a volunteer laboratory to improve the erection, but due to pronounced side effects (a sharp increase in blood pressure), its tests stopped. Later in 2009, the company developing this product announced the results of tests, which reported that the side effect is no longer evident if the drug is injected subcutaneously, and the peptide’s effectiveness remains at an altitude. After all, this drug is a real breakthrough in the treatment of sexual dysfunctions, it can not only improve the erection and sexual arousal, but also effectively combat and treat sexual disorders, regardless of gender. It is possible that in the near future bremelanotide will become the main drug for the treatment of impotence in men and the most effective drug against anorgasmia in women.
Effects of PT-141
The peptide undergoes clinical trials as a means to treat erectile dysfunction and a disorder of sexual desire. In addition, the drug causes a sharp increase in tan (due to stimulation of melanin production by melanocyte cells).
Bremelanotide can be used for both men and women. Unlike Viagra and similar drugs, it not only affects the vessels of the genital organs, but also enhances the sexual desire (desire).
The effect after injection of PT-141 develops within two hours and reaches its peak at the third or fourth hour. The total duration of action is 8-10 hours.
How to use
To introduce RT-141, use an insulin syringe. When injected into the body, the peak concentration of the substance in the blood is reached 3-4 hours after the injection. The active period of the drug lasts up to 10 hours.
The optimal dosage of RT-141 is 0.5-1.5 mg (for a single administration). One bottle is usually enough for 6-8 injections. The vial is injected into the vial through the ampoule wall and mixed with rotational movements. A common form of storage is dilution of the drug, then set into syringes and freeze. Before injection, the drug is thawed.
During the period of application of the Bremelanotide preparation for sunburn enhancement, the sun exposure is shown for 30-60 minutes. In long sunbathing is not necessary, this does not affect the improvement of the effect, but it can cause skin burns and side effects from the drug in the form of pigment spots.
Contraindications and side effects of peptide
Perhaps a slight reddening of the face, which passes through 20-30 minutes after the injection. There were no other side effects even with prolonged use of the peptide as injections.
It is not recommended to use PT-141 intranasally, since this is associated with the risk of developing hypertension.